News

Regeneron’s Lynozyfic Gains Accelerated FDA Approval for Multiple Myeloma
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is one of the most undervalued large cap stocks to buy according to analysts. On ...
PharmExec22h
FDA Grants Accelerated Approval to Regeneron’s Lynozyfic for Relapsed or Refractory Multiple Myeloma
Accelerated approval was based on results from the Phase I/II LINKER-MM1 trial, which showed a 70% objective response rate in ...
Nutrien (NTR) Price Target Raised to $65 at Morgan Stanley
Nutrien Ltd. (NYSE:NTR) is one of the 10 best organic food and farming stocks to buy now. On June 26, Morgan Stanley analyst ...